Top Markets
Coin of the day
Genex Pharmaceutical, Inc. Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc.

GENX
Rank in Stocks #42367
Genex Pharmaceutical, Inc. engages in the development and production of... Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.79K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Genex Pharmaceutical, Inc. (GENX)

Category

Operating Margin for Genex Pharmaceutical, Inc. (GENX)
Operating Margin as of 2026 TTM: 0.00%
According to Genex Pharmaceutical, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Genex Pharmaceutical, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.56% -
IE
0.00% -
CN
0.00% -
CH
0.00% -
CH
0.00% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.